Enochian biosciences inc (ENOB)
Income statement / Yearly
Jun'19Jun'18Jun'17Jun'16Dec'14Dec'13Mar'13Dec'12Mar'12Dec'11
Revenues

-

-

0

-

-

-

0

62

0

0

Cost of Goods Sold

-

-

0

-

-

-

-

-

-

-

Revenues

-

-

-

42

0

32

-

-

-

-

Cost of Goods Sold

-

-

-

5

295

109

-

64

-

-

Gross profit (Loss)

-

-

0

37

-295

-76

-

-1

-

-

Operating Expenses
General and administrative

8,271

3,899

933

1,229

1,644

1,233

37

1,036

29

34

Non-Cash and Stock-Based Compensation Expense

-

-

626

-

-

-

-

-

-

-

Research and development

2,498

616

62

804

0

0

-

-

-

-

Depreciation and amortization

71

18

14

27

18

38

-

56

-

-

Consulting Expenses

148

794

762

96

469

390

-

829

-

-

Total Operating Expense

10,990

5,329

2,400

2,158

2,133

1,662

-

1,922

-

-

LOSS FROM OPERATIONS

-10,990

-5,329

-2,400

-2,120

-2,429

-1,738

-

-1,924

-

-34

Other Income (Expense)
Change in fair value of contingent consideration

-7,073

-1,375

-

-

-

-

-

-

-

-

Interest Income (Expense)

-

-

11

0

-

-

-

-

-

-

Interest expense

0

143

-

-

84

652

0

704

0

-

Interest Income (Expense) - Related Party

-

-

15

2

-

-

-

-

-

-

Gain on forgiveness of debt

-

-

-

-

-

49

-

0

-

-

(Loss) gain on currency transactions

-26

290

218

-74

-40

19

-

32

-

-

Gain on derivative liability

-

-

-

-

-

175

-

153

-

-

Gain on Sale of Assets

-

-

-

-

-

-

-

15

-

-

Other income (expense), forgiveness of debt

-

87

0

-

-

-

-

-

-

-

Interest income

73

45

-

-

-

-

-

-

-

-

Interest and Other Income

-

-

0

0

5

0

-

0

-

-

Total Other Income (Expense)

-7,026

-1,094

192

-77

-119

-408

-

-

-

-

Loss Before Income Taxes

-18,016

-6,423

-2,207

-2,198

-

-

-37

-

-29

-34

Total Other Income (Expense)

-

-

-

-

-

-

-

-503

-

-

(Loss) Before Income Taxes

-

-

-

-

-2,548

-2,147

-37

-2,427

-29

-

Income Tax Benefit

-

-111

-64

-462

-177

0

0

0

0

0

NET LOSS

-18,016

-6,311

-2,142

-1,735

-2,370

-2,147

-37

-

-29

-34

NET (LOSS)

-

-

-

-

-

-

-

-2,427

-

-

BASIC AND DILUTED LOSS PER SHARE

-0.48

-0.29

-0.17

-0.18

-0.32

-0.40

0.00

-0.46

0.00

0.00

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED

37,552

21,940

12,266

9,533

7,500

5,332

5,000

5,318

3,210

-

WEIGHTED AVERAGE BASIC AND DILUTED LOSS PER SHARE

-

-

-

-0.18

-0.32

-0.40

-

-

-

-

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED

-

-

-

-

-

-

-

-

-

0